Emerging market specialist Ashmore has seen a return to positive flows in the quarter to the end of March, as assets under management jumped 7% to $55.9bn.
The firm saw net inflows of $1.4bn, marking the first positive flows in a number of periods, with overlay/liquidity, local currency, external debt and corporate debt themes seeing new money coming in. ...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds